Chuikyo Snubs Industry’s Call to Exclude Listed Products from CEA Scope

Chuikyo HTA Industry Hearing on Dec. 19 Pharma industry associations of Japan, the US, and Europe were invited to give their views on an envisioned Japanese version of a cost-effective assessment (CEA) scheme on December 19, with a key policy...read more